{"result": {"id": "chatcmpl-BU4HJXQyRny6dBITKbAajZfdBBWMm", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>PATIENT PALLIATIVE CARE<|>ORGANIZATION<|>Patient Palliative Care provides specialized inpatient care for patients requiring palliative treatment as per guidelines from the Ministry of Health (MOH).)\n##\n(\"entity\"<|>MINISTRY OF HEALTH<|>ORGANIZATION<|>The Ministry of Health (MOH) sets the relevant guidelines for the provision of medical care, including palliative care.)\n##\n(\"entity\"<|>MULTIPLE MYELOMA<|>BENEFIT<|>Multiple Myeloma is a type of cancer for which the Autologous Bone Marrow Transplant Treatment is provided under specific medical guidelines.)\n##\n(\"entity\"<|>AUTLOGOUS BONE MARROW TRANSPLANT<|>EVENT<|>Autologous Bone Marrow Transplant is a medical procedure for treating Multiple Myeloma, involving several stages including stem-cell mobilisation and engraftment.)\n##\n(\"entity\"<|>COVER START DATE<|>DATE<|>The Cover Start Date is the date from which the insurance policy coverage begins, relevant for determining eligibility for benefits.)\n##\n(\"entity\"<|>SERIOUS PREGNANCY AND DELIVERY-RELATED COMPLICATIONS<|>BENEFIT<|>Serious Pregnancy and Delivery-related Complications are medical conditions that may require hospitalization and are covered under specific circumstances in the insurance policy.)\n##\n(\"entity\"<|>PRE-ECLAMPSIA<|>BENEFIT<|>Pre-eclampsia is a pregnancy complication diagnosed by an obstetrician, which may lead to hospitalization and is covered under the insurance policy.)\n##\n(\"entity\"<|>ECLAMPSIA<|>BENEFIT<|>Eclampsia is a severe pregnancy complication characterized by seizures and is covered under the insurance policy if diagnosed by an obstetrician.)\n##\n(\"entity\"<|>CERVICAL INCOMPETENCY<|>BENEFIT<|>Cervical incompetency is a pregnancy complication diagnosed by an obstetrician, which may require hospitalization and is covered under the insurance policy.)\n##\n(\"entity\"<|>ACCRETA PLACENTA<|>BENEFIT<|>Accreta placenta is a pregnancy complication diagnosed by an obstetrician, which may require hospitalization and is covered under the insurance policy.)\n##\n(\"entity\"<|>PLACENTAL ABRUPTION<|>BENEFIT<|>Placental abruption is a condition where the placenta separates from the uterus after the 20th week of pregnancy, covered under the insurance policy if diagnosed.)\n##\n(\"relationship\"<|>PATIENT PALLIATIVE CARE<|>MINISTRY OF HEALTH<|>Patient Palliative Care operates under the guidelines set by the Ministry of Health for providing specialized care.<|>7)\n##\n(\"relationship\"<|>MULTIPLE MYELOMA<|>AUTLOGOUS BONE MARROW TRANSPLANT<|>The Autologous Bone Marrow Transplant is a treatment specifically designed for patients diagnosed with Multiple Myeloma.<|>8)\n##\n(\"relationship\"<|>COVER START DATE<|>SERIOUS PREGNANCY AND DELIVERY-RELATED COMPLICATIONS<|>The Cover Start Date is crucial for determining when benefits for Serious Pregnancy and Delivery-related Complications begin.<|>6)\n##\n(\"relationship\"<|>SERIOUS PREGNANCY AND DELIVERY-RELATED COMPLICATIONS<|>PRE-ECLAMPSIA<|>Pre-eclampsia is one of the complications covered under the Serious Pregnancy and Delivery-related Complications benefit.<|>8)\n##\n(\"relationship\"<|>SERIOUS PREGNANCY AND DELIVERY-RELATED COMPLICATIONS<|>ECLAMPSIA<|>Eclampsia is another complication that falls under the Serious Pregnancy and Delivery-related Complications benefit.<|>8)\n##\n(\"relationship\"<|>SERIOUS PREGNANCY AND DELIVERY-RELATED COMPLICATIONS<|>CERVICAL INCOMPETENCY<|>Cervical incompetency is included in the list of complications covered under the Serious Pregnancy and Delivery-related Complications benefit.<|>8)\n##\n(\"relationship\"<|>SERIOUS PREGNANCY AND DELIVERY-RELATED COMPLICATIONS<|>ACCRETA PLACENTA<|>Accreta placenta is a complication that is covered under the Serious Pregnancy and Delivery-related Complications benefit.<|>8)\n##\n(\"relationship\"<|>SERIOUS PREGNANCY AND DELIVERY-RELATED COMPLICATIONS<|>PLACENTAL ABRUPTION<|>Placental abruption is a complication that is included in the Serious Pregnancy and Delivery-related Complications benefit.<|>8)\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": [], "audio": null, "function_call": null, "tool_calls": null}}], "created": 1746505985, "model": "gpt-4o-mini-2024-07-18", "object": "chat.completion", "service_tier": "default", "system_fingerprint": "fp_0392822090", "usage": {"completion_tokens": 985, "prompt_tokens": 2237, "total_tokens": 3222, "completion_tokens_details": {"accepted_prediction_tokens": 0, "audio_tokens": 0, "reasoning_tokens": 0, "rejected_prediction_tokens": 0}, "prompt_tokens_details": {"audio_tokens": 0, "cached_tokens": 1664}}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,benefit,date,event,location]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,benefit,date,event,location\nText: patient Palliative \nCare, up to the limits as set out in the Benefits Schedule.\nThe life assured must be admitted for Specialised Inpatient Palliative Care by a Registered Medical \nPractitioner, according to the relevant guidelines from MOH.\n2.4.2.10 What do we pay for Continuation of the Autologous Bone Marrow Transplant \nTreatment for Multiple Myeloma?\nWe reimburse the Reasonable and Customary Expenses incurred, up to the limits as set out in the \nBenefits Schedule, if the life assured undergoes Medically Necessary Autologous Bone Marrow \nTransplant Treatment for Multiple Myeloma for the following stages of the treatment:\n- Stem-cell mobilisation\n- Harvesting healthy stem cells\n- Pre-transplant workup\n- Use of high dosage chemotherapeutic drugs to destroy cancerous cells\n- Engraftment of healthy stem cells\n- Post-transplant monitoring\nWe pay for all treatment costs, including consultation, clinical and lab investigations, consumables and \ndrugs needed for the Continuation of Autologous Bone Marrow Transplant Treatment for Multiple \nMyeloma in the outpatient setting. This applies strictly to treatment in the outpatient setting only. If the life assured requires certain phases \nof bone marrow transplant in the inpatient setting, these treatments will be covered under the \nprevailing inpatient limits.\nThis benefit is subject to the Deductible, Co-insurance and Pro-ration.\n2.4.2.11 What do we pay for Serious Pregnancy and Delivery-related Complications?\nWe will reimburse expenses incurred if the life assured is hospitalised as a result of the pregnancy \ncomplication conditions listed below. These pregnancy complications must have been first diagnosed \nafter 10 months from the:\n- Cover Start Date of the policy; or\n- date of reinstatement (if any),\nwhichever is later.\nWe do not pay for delivery charges, except in the event of a Caesarean Section with Hysterectomy.\n1) Pre-eclampsia and eclampsia\nThe diagnosis of pre-eclampsia or eclampsia by an obstetrician.\n2) Cervical incompetency\nThe diagnosis of cervical incompetency by an obstetrician.\n3) Accreta placenta\n The diagnosis of accreta placenta by an obstetrician.\n4) Placental abruption\nThis is the separation of the normally implanted placenta after the 20th week\n######################\nOutput:", "role": "user"}], "parameters": {"model": "gpt-4o-mini", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}}